41
TITLE: Application of the Quality-by-Design (QbD) Approach to Improve the Nose-to-Brain Delivery of Diazepam-Loaded Nanostructured Lipid Carriers (NLCs)  Full Text
AUTHORS: Cláudia Pina Costa; Sara Cunha; Andreia F. Peixoto ; João Nuno Moreira; José Manuel Sousa Lobo; Ana Catarina Silva ;
PUBLISHED: 2020, SOURCE: Proceedings, VOLUME: 78, ISSUE: 1
INDEXED IN: CrossRef: 1
IN MY: ORCID
42
TITLE: Hematopoietic Growth Factors
AUTHORS: Ana Catarina Silva ; João Nuno Moreira; José Manuel Sousa Lobo;
PUBLISHED: 2020, SOURCE: Encyclopedia of Molecular Pharmacology
INDEXED IN: CrossRef
IN MY: ORCID
43
TITLE: Nose-to-brain delivery of lipid-based nanosystems for epileptic seizures and anxiety crisis  Full Text
AUTHORS: Costa, C; Moreira, JN; Amaral, MH ; Sousa Lobo, JMS ; Silva, AC ;
PUBLISHED: 2019, SOURCE: JOURNAL OF CONTROLLED RELEASE, VOLUME: 295
INDEXED IN: Scopus WOS CrossRef: 71
IN MY: ORCID
44
TITLE: Quantification of the difference between Cardiac Magnetic Resonance signals in perfusion studies with and without motion correction algorithms
AUTHORS: Moreira, T; Almeida, N; Bettencourt, N ; Coimbra, M ;
PUBLISHED: 2019, SOURCE: 6th IEEE Portuguese Meeting on Bioengineering (ENBENG) in 2019 6TH IEEE PORTUGUESE MEETING IN BIOENGINEERING (ENBENG)
INDEXED IN: Scopus WOS CrossRef
45
TITLE: Study of rdxA and frxA genes mutations in metronidazole-resistant and -susceptible Helicobacter pylori clinical isolates from the central region of Portugal  Full Text
AUTHORS: Bruno Marques; Maria Manuel Donato ; Olga Cardoso ; Cristina Luxo; Antonio Martinho; Nuno Almeida;
PUBLISHED: 2019, SOURCE: JOURNAL OF GLOBAL ANTIMICROBIAL RESISTANCE, VOLUME: 17
INDEXED IN: Scopus WOS CrossRef: 1
46
TITLE: Nucleolin-based targeting strategies for cancer therapy: from targeted drug delivery to cytotoxic ligands
AUTHORS: Romano, S; Fonseca, N; Simoes, S; Goncalves, J; Moreira, JN;
PUBLISHED: 2019, SOURCE: DRUG DISCOVERY TODAY, VOLUME: 24, ISSUE: 10
INDEXED IN: Scopus WOS CrossRef: 56
IN MY: ORCID
47
TITLE: Differential effect of liposomal C6-ceramide/doxorubicin targeted to nucleolin and conventional combinations against triple negative
AUTHORS: Ana F Cruz; Nuno A Fonseca; Nelio Goncalves; Vera Moura; Sergio Simoes; Joao Nuno Moreira;
PUBLISHED: 2019, SOURCE: Annual Meeting of the American-Association-for-Cancer-Research (AACR) in CANCER RESEARCH, VOLUME: 79, ISSUE: 13
INDEXED IN: WOS
48
TITLE: In vivo targeting of mesothelioma's molecular signature with nanoparticle functionalized with nucleolin-binding peptide
AUTHORS: Fonseca, NA; Moura, V; Colelli, F; Pesce, D; Signorino, G; Focareta, L; Fucci, A; Cardile, F; Pisano, C; Simoes, S; Moreira, JN;
PUBLISHED: 2019, SOURCE: Annual Meeting of the American-Association-for-Cancer-Research (AACR) in CANCER RESEARCH, VOLUME: 79, ISSUE: 13
INDEXED IN: WOS CrossRef
IN MY: ORCID
50
TITLE: Nucleolin: A novel cell surface protein for neuroblastoma targeted therapy
AUTHORS: Chiara, B; Bensa, V; Del Zotto, G; Bruno, S; Fonseca, NA; Cruz, AF; Di Paolo, D; Perri, P; Moura, V; Emionite, L; Cilli, M; Ponzoni, M; Moreira, JN; Pastorino, F;
PUBLISHED: 2019, SOURCE: MOLECULAR CANCER THERAPEUTICS, VOLUME: 18, ISSUE: 12
INDEXED IN: WOS CrossRef
IN MY: ORCID
Page 5 of 13. Total results: 125.